Literature DB >> 31168873

ELK1-activated GPC3-AS1/GPC3 axis promotes the proliferation and migration of cervical cancer cells.

Rong Hu1, Zongming Zhu2.   

Abstract

BACKGROUND: Long non-coding RNA (lncRNA) is reported to be involved in multiple biological processes in numerous human tumors. Furthermore, an increasing number of studies have confirmed the involvement of lncRNA in the initiation and development of human cancers, including cervical cancer (CC).
METHODS: The present study explored the potential role of lncRNA glypican 3 antisense transcript 1 (GPC3-AS1) with respect to regulating CC cell proliferation and migration.
RESULTS: A quantitative reverse transcriptase-polymerase chain reaction confirmed that GPC3-AS1 was up-regulated in CC cells compared to normal CRL-2614 cells. Loss-of-function assays demonstrated the negative effect of GPC3-AS1 depletion on CC cell proliferation and migration. GPC3-AS1 positively regulated its nearby gene glypican 3 (GPC3). Significant up-regulation of GPC3 was also observed in CC cells, consistently with GPC3-AS1. In addition, GPC3-AS1 and GPC3 synergistically promoted the proliferative and migratory abilities of CC cells. Mechanistic investigation showed that ELK1 acted as the transcription activator of GPC3-AS1 and GPC3, thus contributing to their up-regulation in CC cells. Rescue assays indicated that the ELK1-induced GPC3-AS1/GPC3 axis promoted cell proliferation and migration in CC.
CONCLUSIONS: The results of the present study have revealed a novel molecular pathway that can regulate CC cell proliferation and migration, thus providing a new basis for investigating the molecular mechanism associated with CC progression.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ELK1; GPC3; GPC3-AS1; cervical cancer

Year:  2019        PMID: 31168873     DOI: 10.1002/jgm.3099

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  5 in total

1.  Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway.

Authors:  Liyan Wang; Bin Li; Xiaotong Bo; Xiaoyuan Yi; Xuhua Xiao; Qinghua Zheng
Journal:  Exp Mol Med       Date:  2022-06-28       Impact factor: 12.153

2.  ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis.

Authors:  Hangzhi Gu; Rongrong Lin; Feiyun Zheng; Qian Zhang
Journal:  J Mol Histol       Date:  2020-10-24       Impact factor: 2.611

3.  LncRNA BCRT1 facilitates osteosarcoma progression via regulating miR-1303/FGF7 axis.

Authors:  Gang Han; Quanyi Guo; Ning Ma; Wenzhi Bi; Meng Xu; Jinpeng Jia; Wei Wang
Journal:  Aging (Albany NY)       Date:  2021-06-08       Impact factor: 5.682

4.  CD105 expression is associated with invasive capacity in ovarian cancer and promotes invasiveness by inhibiting NDRG1 and regulating the epithelial-mesenchymal transition.

Authors:  Jin Zhang; Xiubo Sang; Rui Zhang; Jingjing Chi; Wenpei Bai
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma.

Authors:  Fangfang Li; Chun Huang; Lingxiao Qiu; Ping Li; Jiang Shi; Guojun Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-08       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.